Early detection of heart arrhythmias.
Why monitor your heart?
Irregular heart rhythms are alarmingly common. In the U.S, an individual's lifetime risk of developing AFib is roughly 1 in 4.1 And yet, many who experience this don't even feel symptoms and aren't aware that they have it.2 Arrhythmias are a leading cause of stroke and increase the risk of other serious outcomes.3,5
The good news is that long-term, continuous heart monitoring is helping in the shift to more preventative and proactive treatment and care.2
![irhythm-patch-kyr](https://www.irhythmtech.com/hubfs/_wrz/images/know-your-rhythm/irhythm-patch-kyr.jpg)
Why monitor your heart?
Irregular heart rhythms are alarmingly common. In the U.S, an individual's lifetime risk of developing AFib is roughly 1 in 4.1 And yet, many who experience this don't even feel symptoms and aren't aware that they have it.2 Arrhythmias are a leading cause of stroke and increase the risk of other serious outcomes.3,5
The good news is that long-term, continuous heart monitoring is helping in the shift to more preventative and proactive treatment and care.2
Easy-to-wear
cardiac monitoring.
![irhythm-zio-patch](https://www.irhythmtech.com/hubfs/_wrz/images/know-your-rhythm/irhythm-zio-patch.png)
How does it work?
The details.
Payers + Healthcare ProvidersWant to learn more?
- Staerk, et al., Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018.
- mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for At-Risk Patient Populations, iRhythm Technologies, 2021.
- Wolf, et al., Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991.
- Sgreccia, et al., Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. Journal of Clinical Medicine MDPI, 2021.
- Kotecha, et al., Atrial fibrillation in heart failure: what should we do? Eur Heart J., 2015.
- Alkhouli, et al., Burden of Atrial Fibrillation–Associated Ischemic Stroke in the United States. JACC: Clinical Electrophysiology, 2018.
- Steinhubl, et al. Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening—mHealth Screening to Prevent Strokes (mSToPS). PLOS ONE, 2021.
- Market survey of 200 respondents currently enrolled in a Medicare Advantage plan. Data on file. iRhythm Technologies, 2022.
- Directional and potential outcome based upon modeling using iRhythm’s mSToPS
Calculator. iRhythm Technologies, 2023.
*Assumes 10,000 members, 2,500 eligible with 25% participation. - Waalen, et al. Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation. Heart Rhythm O2, 2020.